
Xalibo 50mg Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Decitabine (50mg)
Overview Xalibo 50mg Injection
Azacitidine 50mg injection treats acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Its use may extend to other conditions as directed by a physician. This medication, often administered intravenously as part of combination chemotherapy, requires careful dosage monitoring and adherence to a doctor's prescription. The prescribed frequency and dosage will vary depending on your condition and may be adjusted. Incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might take weeks or months to appear, discontinuation should only occur under medical guidance. Common side effects include nausea, vomiting, diarrhea, headache, fever, and pneumonia. Azacitidine can decrease blood cell counts, increasing infection risk. Regular blood tests to monitor blood cells, along with heart, liver, and uric acid levels are essential. Prior to treatment, disclose any heart, liver, or kidney issues, or the use of infection-fighting drugs. Interactions with other medications are possible; inform your doctor of all medications you are taking. This injection is contraindicated during pregnancy and breastfeeding. Reliable contraception for both partners is crucial throughout treatment to prevent conception.
Primary Ingredients of Xalibo 50mg Injection
No information provided. Please provide the text you wish to be rephrased.
Uses of Xalibo 50mg Injection
Bone marrow failure disorder | Hematologic malignancy
Major Benefits of Xalibo 50mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Xalibo 50mg Injection:
- Nausea
- Vomiting
- Headache
- Fever
- Lung infection
- Decreased white blood cell count (neutrophils)
- Nosebleeds
- Anemia (low number of red blood cells)
- Low blood platelets
- Diarrhea
- Pneumonia
How to use Xalibo 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Xalibo 50mg Injection works:
Xalibo 50mg Injection halts cancer cell proliferation by disrupting DNA and RNA synthesis through the replacement of essential cellular components. This action inhibits the growth and replication of cancerous cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Xalibo 50mg Injection is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Administering Xalibo 50mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore inadvisable. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Xalibo 50mg Injection is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Administration of Xalibo 50mg Injection may induce adverse reactions that impair driving capabilities. Fatigue or weakness following Xalibo 50mg Injection administration may also compromise driving ability.
KidneyCAUTION
Patients with impaired kidney function should use Xalibo 50mg Injection with care. A modified dosage of Xalibo 50mg Injection might be necessary. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of Xalibo 50mg Injection to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Xalibo 50mg Injection :
NA
Facts to Know About Xalibo 50mg Injection
| Label | Value |
|---|---|
| Chemical Type | Azacitidine Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Active Class | Metabolic Inhibitors |
